​

Episode 6 of this series of the Mantell Associates Network welcomes Dr Marcus Kostka, Chief Executive Officer at Abalos Therapeutics GmbH.

​

Dr Marcus Kostka is a highly experienced biotech industry expert. Prior to joining Abalos as CEO, he held various roles at Boehringer Ingelheim, his latest position being Venture Fund Partner since 2014. In this role, Marcus Kostka was a board member in EtheRNA NV, Cardio Pharmaceutical, Aelin Therapeutics and Rewind Therapeutics.

​

​

Abalos Therapeuticshas harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Led by experienced biotech entrepreneurs and immunology pioneers, Abalos’ goal is to achieve a quantum leap in immuno-oncology.

The aim of the Mantell Associates Network Podcast is to connect people all around the world and empower people and businesses by sharing the stories, advice and outlook of influential leaders at market-leading companies across the industry. This podcasts provides exposure for the individuals and businesses currently doing great things, and works to unify the Pharmaceutical & Life Science industry. You can also listen this podcasts on the following streams:

​

​

​

Mantell Associates is a specialist Pharmaceutical and Life Sciences Recruitment organisation. To find out how we can help with your headhunting or recruitment needs, or if joining us on the podcast and sharing your experience with the rest of the Pharmaceutical & Life Science industry is something you’d be interested in doing, contact us on +44 (0)20 3854 7700.